Metformin and Anesthesia: What Every Woman Needs to Know Before Surgery

The Short Answer on Metformin and Anesthesia

If you take metformin and are scheduled for surgery, you should not simply take your usual dose the morning of the procedure without checking with your clinical team first. The standard clinical instruction is to hold metformin on the day of surgery, and many guidelines extend that hold to 24 to 48 hours beforehand when major or prolonged anesthesia is planned. The reason is not that metformin directly interacts with anesthetic drugs in the conventional sense. The concern is physiological: surgery, anesthesia, and the fasting state together can reduce kidney perfusion, and metformin depends almost entirely on renal clearance.

When kidneys clear metformin more slowly, plasma levels can rise to the point where lactate metabolism is impaired, a rare but life-threatening condition called metformin-associated lactic acidosis (MALA). The FDA label for metformin warns explicitly that metformin is contraindicated in patients with conditions associated with hypoxemia, dehydration, or sepsis because these states all reduce renal blood flow and increase lactate production.

Why Anesthesia Specifically Triggers This Risk

General anesthesia causes vasodilation and can drop mean arterial pressure, reducing renal perfusion even in healthy patients. Add surgical bleeding, prolonged fasting, IV contrast (if used intraoperatively), or postoperative nausea that prevents adequate hydration, and the conditions for metformin accumulation are present. A 2019 review published in Anaesthesia found that while absolute MALA incidence remains low (estimated at 3 to 10 cases per 100,000 patient-years), mortality when MALA does occur is approximately 30 to 50 percent, making prevention the only rational strategy.

Metformin has a half-life of roughly 6.5 hours under normal renal function, but this extends dramatically as eGFR falls. If your eGFR is 45 mL/min/1.73 m², metformin clearance is substantially impaired even before surgery begins.

What "Hold Metformin" Actually Means in Practice

"Hold" means skip those doses. It does not mean taper. It does not mean take a half dose. Clinical guidance from the American Society of Anesthesiologists and consensus statements align on the following framework:

• Day before major surgery: Hold the evening dose if your procedure involves general or neuraxial anesthesia lasting more than one hour, or if any intraoperative contrast is planned.
• Morning of surgery: Hold the morning dose without exception for any surgical procedure requiring anesthesia.
• Minor procedures under local anesthesia only: Discuss with your prescriber, but holding the morning dose is still common practice.
• Restart: Resume metformin once you are eating normally, your creatinine is back to baseline (or confirmed stable), and you are adequately hydrated, typically 24 to 48 hours postoperatively for major surgery.

How This Differs Across Women's Life Stages

Metformin is one of the most widely prescribed drugs in women of all ages. It is first-line for type 2 diabetes, widely used off-label for PCOS, and increasingly used in gestational diabetes and even perimenopause-related insulin resistance. The perioperative calculus changes meaningfully depending on where you are in your reproductive life.

Reproductive Years and PCOS

Women with PCOS are among the most common metformin users outside of type 2 diabetes. If you have PCOS and are undergoing a procedure such as laparoscopy for endometriosis, ovarian drilling, or any elective gynecological surgery, the same hold rules apply. There is no gynecological-specific exemption. ACOG Practice Bulletin No. 194 notes that metformin reduces hyperinsulinemia and androgen levels in PCOS but does not address surgical exceptions, meaning the standard perioperative framework governs.

For egg retrieval in IVF cycles, the situation is slightly different. Oocyte retrieval is typically performed under IV sedation with short procedure time and minimal hemodynamic disturbance. Some reproductive endocrinologists continue metformin through egg retrieval in women with PCOS to reduce ovarian hyperstimulation syndrome (OHSS) risk. A 2016 Cochrane review found that metformin reduces OHSS incidence in PCOS patients undergoing IVF. Whether to continue or hold in this specific context is a decision for your reproductive endocrinologist, not a unilateral self-management choice.

Trying to Conceive

If you are taking metformin to support ovulation or improve cycle regularity and you need an unrelated surgical procedure, the hold schedule is identical to any other patient. However, you and your surgical team should note that metformin is sometimes continued into the first trimester after IVF or spontaneous conception in women with PCOS or a history of early pregnancy loss. A 2017 randomized controlled trial published in BJOG found that metformin continued through the first trimester reduced early pregnancy loss in PCOS but did not demonstrate benefit beyond 12 weeks. If you conceive shortly before a planned elective procedure, surgery timing should be reconsidered with your OB.

Pregnancy

Metformin crosses the placenta. This is not a contraindication in itself but it is a fact that shapes every perioperative decision in a pregnant woman. Metformin is FDA Pregnancy Category B: animal studies show no fetal harm and adequate human data exist for gestational diabetes management, though metformin was not tested in large randomized trials specifically for perioperative safety in pregnancy.

If you have gestational diabetes managed with metformin and you need a cesarean section or any urgent surgery, your obstetric anesthesia team needs to know your metformin dose and timing. The concern is not teratogenicity at this stage. The concern is hemodynamic instability during surgery reducing uteroplacental perfusion while metformin clearance is impaired. For planned cesarean delivery, metformin is routinely held the night before. For emergency cesarean, the anesthesiologist proceeds with surgery and manages glucose and lactate monitoring perioperatively. The MiG Trial (Metformin in Gestational Diabetes), published in the New England Journal of Medicine in 2008, established metformin's safety profile in pregnancy for glycemic control but did not address perioperative use specifically.

Elective surgery during pregnancy that requires general anesthesia is avoided unless medically necessary regardless of metformin status. If you are pregnant and scheduled for an elective non-obstetric procedure, that procedure should generally be deferred until after delivery.

Postpartum and Lactation

Metformin does transfer into breast milk, but at low levels. A pharmacokinetic study published in Diabetic Medicine found that infant exposure via breast milk was approximately 0.28 percent of the maternal weight-adjusted dose, well below the 10 percent threshold conventionally considered concerning. The Academy of Breastfeeding Medicine and most endocrinology guidelines consider metformin compatible with breastfeeding.

If you are postpartum and breastfeeding and need surgery, hold metformin perioperatively per the standard schedule. There is no need to pump and discard milk specifically because of metformin. The perioperative hold is about your safety, not neonatal exposure. Resume metformin and breastfeeding on the same timeline once kidney function and oral intake are confirmed stable.

Perimenopause and Postmenopause

This is the life stage with the highest individual risk for MALA during surgery. Renal function declines gradually with age, and many perimenopausal women do not realize their eGFR has drifted downward. A woman who was comfortably in the eGFR 70 to 80 range at 40 may be at 50 to 60 by 55 without any symptoms. Data from the CKD-EPI Collaboration confirm that eGFR declines on average 0.7 to 1 mL/min/1.73 m² per year after age 40, faster in women with hypertension or metabolic syndrome, both of which track with menopause-related cardiometabolic changes.

Postmenopausal women on metformin for type 2 diabetes or off-label metabolic support should have their renal function checked preoperatively. If eGFR is found to be <60 on preoperative labs, the anesthesia and prescribing teams need to revisit the entire metformin dose strategy, not just the perioperative hold.

The Lactic Acidosis Risk: What the Evidence Actually Shows

Metformin-associated lactic acidosis is real but statistically uncommon in patients with normal renal function. Understanding the actual numbers helps you have an informed conversation with your team rather than a fear-driven one.

A large Danish cohort study published in the BMJ in 2015 followed over 55,000 patients with type 2 diabetes and found no elevated rate of lactic acidosis in metformin users compared with non-users when kidney function was normal. The same study found that restriction of metformin use in mild to moderate CKD (eGFR 30 to 60) may be overly conservative based on absolute risk, but this was not evaluated specifically in the perioperative context.

The perioperative period is physiologically distinct from outpatient stable-disease use. Intraoperative hypotension, blood loss, contrast nephropathy, and postoperative acute kidney injury can each temporarily drop effective eGFR by 20 to 40 percent. This transient functional impairment is enough to cause metformin accumulation even in a patient who was safely below the 45 mL/min threshold the week before surgery.

What Lactic Acidosis Looks Like

If MALA does develop perioperatively, the presenting symptoms are nausea, vomiting, abdominal pain, and confusion, overlapping substantially with normal postoperative recovery. This diagnostic overlap is exactly why prevention (holding the drug) is more reliable than recognition and rescue. Arterial lactate above 5 mmol/L with a low pH confirms the diagnosis. Treatment requires stopping metformin, aggressive IV hydration, and in severe cases, hemodialysis to clear metformin rapidly. A case series in Intensive Care Medicine documented that hemodialysis reduces plasma metformin levels by approximately 50 percent within two hours and reverses acidosis.

Metformin and Iodinated Contrast: A Separate But Related Hold

Imaging procedures using iodinated contrast dye deserve their own explanation because many women encounter this rule in radiology departments and misunderstand it as equivalent to surgical anesthesia. It is a related but distinct scenario.

Iodinated contrast can cause contrast-induced nephropathy (CIN), a transient drop in renal function. If your kidneys are acutely impaired by contrast and metformin is on board, MALA risk rises. FDA guidance updated in 2016 specifies:

• If eGFR is <60 mL/min/1.73 m²: hold metformin at the time of contrast and for 48 hours after. Recheck renal function before restarting.
• If eGFR is 60 or above and you have no acute illness: metformin does not need to be held for routine outpatient contrast imaging, though some radiology departments still apply the older blanket hold policy.

This FDA update matters for women with PCOS who undergo frequent pelvic MRIs or CTs, and for perimenopausal women who may have borderline eGFR without realizing it.

Who Should Be Most Cautious

Not every woman on metformin carries the same perioperative risk. The following framework reflects the clinical stratification used by anesthesiology and endocrinology teams, synthesized specifically for female patients across life stages at WomanRx:

Highest caution group:

• Postmenopausal women with eGFR 30 to 59 and planned major abdominal or cardiac surgery
• Women with type 2 diabetes and baseline creatinine above 1.2 mg/dL
• Women receiving nephrotoxic drugs concurrently (NSAIDs, aminoglycosides)
• Pregnant women with gestational diabetes requiring urgent non-obstetric surgery

Moderate caution group:

• Perimenopausal women with eGFR 60 to 75 and planned surgery lasting more than two hours
• Women with PCOS undergoing laparoscopic surgery under general anesthesia
• Any woman with planned intraoperative contrast use

Standard protocol group (hold day-of-surgery, resume when eating):

• Reproductive-age women with normal renal function (>90 mL/min) on metformin for PCOS or early type 2 diabetes
• Postpartum women undergoing minor gynecological procedures

Who Metformin Is Right For and Who Should Reconsider

Metformin remains one of the safest and most evidence-backed drugs in women's health. The perioperative interaction is manageable, not a reason to discontinue the drug long-term. For elective surgery, the conversation should be:

• Inform your surgeon and anesthesiologist that you take metformin at your preoperative assessment.
• Have your eGFR checked preoperatively if you are over 50 or have any history of kidney disease.
• Ask your prescribing clinician to write a clear perioperative hold instruction in your chart.
• Carry a medication list that includes your metformin dose and frequency.

If you have been told by a surgeon or anesthesiologist to simply stop metformin but no one has told you when to restart, contact your prescriber within 48 hours of surgery. Prolonged unnecessary discontinuation in women with PCOS can allow insulin resistance to worsen, and in type 2 diabetes it can cause hyperglycemia that complicates wound healing. A retrospective cohort study in Diabetes Care found that perioperative hyperglycemia in women with type 2 diabetes was independently associated with increased surgical site infection rates, reinforcing that the goal is a brief, targeted hold, not abandonment of glycemic control.

Alcohol and Metformin: The Perioperative Connection

The secondary query about alcohol and metformin is directly relevant here because alcohol is itself a risk factor for lactic acidosis when combined with metformin, and surgical patients are often instructed to avoid alcohol preoperatively anyway.

The FDA metformin label states that patients should avoid excessive alcohol while taking metformin because alcohol potentiates the effect of metformin on lactate metabolism. Heavy acute intake, defined as more than three standard drinks per occasion, can impair hepatic lactate clearance independent of the drug, and the combination raises MALA risk.

For perioperative planning, if you regularly drink alcohol, disclose this to your anesthesiologist. Alcohol withdrawal can complicate postoperative recovery and interact with anesthetic agents. The practical instruction is to avoid alcohol for at least 48 hours before any planned surgical procedure if you are on metformin, and throughout the hold period.

Pregnancy and Lactation Safety Summary

Pregnancy classification: FDA Pregnancy Category B. Human data from the MiG Trial and multiple observational studies show no increased congenital malformation risk. The MiG Trial randomized 751 women with gestational diabetes; neonatal outcomes were similar between metformin and insulin groups. Long-term follow-up data from the MiG TOFU study suggest offspring of metformin-treated mothers have higher body fat at age 7 to 9, a finding whose clinical meaning is still being examined.

Placental transfer: Metformin crosses the placenta freely. Fetal concentrations may equal or exceed maternal levels. This is not an absolute contraindication but must be considered when metformin is held perioperatively in a pregnant patient, as the fetus will clear the drug more slowly.

Lactation: Compatible with breastfeeding per the Academy of Breastfeeding Medicine Protocol. Relative infant dose is approximately 0.28 percent of maternal dose. No adverse infant effects have been reported in published case series.

Contraception note: Metformin is not a contraceptive. Women with PCOS on metformin who are not trying to conceive and who may become more ovulatory on the drug must use reliable contraception. This is directly relevant perioperatively if hormonal contraception needs to be adjusted around surgery (some providers hold combined oral contraceptives before major surgery to reduce VTE risk, creating a gap in contraceptive cover).

"Women with PCOS who achieve regular cycles on metformin often assume they cannot get pregnant," notes ACOG's Practice Bulletin on PCOS. "Restoration of ovulation means contraception is required if pregnancy is not the goal."

What to Tell Your Surgical Team

Come to your preoperative appointment with:

1. The name, dose, and frequency of your metformin (e.g., metformin extended-release 1,000 mg twice daily).
2. Your most recent eGFR or serum creatinine if you have it.
3. Any history of kidney disease, heart failure, liver disease, or prior lactic acidosis.
4. Whether you are pregnant, breastfeeding, or may be pregnant.
5. Your alcohol use (honest disclosure; your surgical safety depends on it).
6. Any upcoming imaging with contrast within 48 hours of your surgery date.

Your anesthesiologist should confirm the hold schedule in writing. If you leave the preoperative appointment without a clear written instruction on when to stop and when to restart metformin, ask before you leave.